EP0680337A4
Methods and compositions for the direct concentrated delivery of passive immunity.
2 sheets
Sheet 1 Sheet 2
Every citation, both waysCites: the store holds 9 of 10
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| EP0127712A1 | Cites | European Patent Office (EPO) | X | Search report | 5-14,17-23,26,27 |
| EP0168830A2 | Cites | European Patent Office (EPO) | X | Search report | 1-4,7-14,23-26 |
| EP0201004A2 | Cites | European Patent Office (EPO) | X | Search report | 1-4,7-14,23-26 |
| GB2186592A | Cites | United Kingdom | X | Search report | 5-14,17-23,26-29 |
| US4994269A | Cites | United States of America | – | Examiner | – |
| WO9008834A1 | Cites | World Intellectual Property Organization (WIPO) | – | Examiner | – |
| EP0127712A | Cites | European Patent Office (EPO) | – | – | – |
| EP0168830A | Cites | European Patent Office (EPO) | – | – | – |
| EP0201004A | Cites | European Patent Office (EPO) | – | – | – |
| VOX SANG, vol. 28, 1975, pages 422 - 437 | Non-patent | – | – | Examiner | – |
| INFECTION, vol. 15, 1987, pages S51 - S59 | Non-patent | – | – | Examiner | – |
| See also references of WO 9415640A1 | Non-patent | – | – | Examiner | – |
60 members in 11 offices
Priority claims7
| Document | Office | Kind | Date |
|---|---|---|---|
| 19930003305 | United States of America | – | |
| 330593 | United States of America | A | |
| 330593 | United States of America | A | |
| 9400410 | United States of America | W | |
| 9400410 | United States of America | W | |
| US19930003305 | – | – | – |
| WO1994US00410 | – | – | – |
Members60
| Document | Office | Kind | |
|---|---|---|---|
| CA2153661A1 | Canada | A1 | |
| WO9415640A1 | World Intellectual Property Organization (WIPO) | A1 | |
| CA2171314A1 | Canada | A1 | |
| WO9507526A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7314694A | Australia | A | |
| EP0680337A1 | European Patent Office (EPO) | A1 | |
| US5505945A | United States of America | A | |
| US5530102A | United States of America | A | |
| EP0722601A1 | European Patent Office (EPO) | A1 | |
| JPH08508240A | Japan | A | |
| KR960705297A | Republic of Korea | A | |
| US5625765A | United States of America | A | |
| JPH09505138A | Japan | A | |
| EP0680337A4This record | European Patent Office (EPO) | A4 | |
| CA2243557A1 | Canada | A1 | |
| WO9726914A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US5681565A | United States of America | A | |
| US5682332A | United States of America | A | |
| CA2258025A1 | Canada | A1 | |
| WO9748037A1 | World Intellectual Property Organization (WIPO) | A1 | |
| NZ269318A | New Zealand | A | |
| AU3486497A | Australia | A | |
| US5707627A | United States of America | A | |
| US5718899A | United States of America | A | |
| US5742521A | United States of America | A | |
| AU691508B2 | Australia | B2 | |
| EP0722601A4 | European Patent Office (EPO) | A4 | |
| US5815411A | United States of America | A | |
| US5817312A | United States of America | A | |
| WO9847104A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2730697A | Australia | A | |
| EP0876157A1 | European Patent Office (EPO) | A1 | |
| CH689904A5 | Switzerland | A5 | |
| EP0979443A1 | European Patent Office (EPO) | A1 | |
| US6031545A | United States of America | A | |
| US6037936A | United States of America | A | |
| KR20000016604A | Republic of Korea | A | |
| US6064398A | United States of America | A | |
| JP2000508620A | Japan | A | |
| JP2000512781A | Japan | A | |
| NZ333362A | New Zealand | A | |
| AU726106B2 | Australia | B2 | |
| EP0876157A4 | European Patent Office (EPO) | A4 | |
| CA2171314C | Canada | C | |
| US6278461B1 | United States of America | B1 | |
| US6307556B1 | United States of America | B1 | |
| US6414696B1 | United States of America | B1 | |
| US2002163521A1 | United States of America | A1 | |
| EP0722601B1 | European Patent Office (EPO) | B1 | |
| AT256327T | Austria | T | |
| ATE256327T1 | Austria | T1 | |
| DE69433405D1 | Germany | D1 | |
| JP3700021B2 | Japan | B2 | |
| EP0979443A4 | European Patent Office (EPO) | A4 | |
| US7301536B2 | United States of America | B2 | |
| US2008068400A1 | United States of America | A1 | |
| JP4294093B2 | Japan | B2 | |
| US7916138B2 | United States of America | B2 | |
| US2011157223A1 | United States of America | A1 | |
| CA2258025C | Canada | C |
8 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Application deemed to be withdrawnWithdrawn18D | 18D | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA | STAA | |
| First examination report despatched17Q | 17Q | |
| Supplementary search report drawn up and despatchedA4 | A4 | |
| Designated contracting statesAK | AK | |
| Request for examination filed17P | 17P | |
| Designated contracting statesAK | AK | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI |
Numbers
- Publication
- 0680337
- Publication, DOCDB
- 0680337
- Publication, EPODOC
- EP0680337
- Application
- 94909448
- Application, DOCDB
- 94909448
- Application, EPODOC
- EP19940909448
Titles3
- English
- METHODS AND COMPOSITIONS FOR THE DIRECT CONCENTRATED DELIVERY OF PASSIVE IMMUNITY
- French
- PROCEDES ET COMPOSITIONS POUR APPLICATION DIRECTE A FORTE CONCENTRATION D'ANTICORPS, PRODUISANT UNE IMMUNITE PASSIVE
- German
- METHODEN UND ZUSAMMENSETZUNGEN ZUR DIREKTER KONZENTRIERTER VERABREICHUNG PASSIVER IMMUNITÄT
Classification
- CPC, 9
- A61K39/44
- A61K38/00
- C07K16/12
- C07K16/1214
- C07K16/1271
- A61P11/00
- A61P17/00
- A61P27/16
- Y02A50/30
- IPC, 12
- A61K9 02
- A61K9 06
- A61K9 08
- A61K38 00
- A61K39 395
- A61K39 44
- A61L27 00
- A61L29 00
- A61P11 00
- A61P17 00
- A61P27 16
- C07K16 12
Designated states1
- Contracting states, 1
- Sweden
